Just reported
From GE HealthCare Technologies's results release of October 28, 2026; its quarterly report has since been filed.
Actual
$5.51B
+7.2% y/y
+4.1% q/q
Guided
—
No guide given
Actual
$1.36
+39% y/y
+9.7% q/q
Guided
—
No guide given
Actual
$805M
+23% y/y
+8.9% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Shares of revenue are estimates for nine months ended September 30, 2026, not figures from a filing.
Computed tomography scanners
Scanners use X-rays to create cross-sectional and three-dimensional images that can help clinicians find problems such as tumors, blocked blood vessels, or fractures.
Magnetic resonance scanners
Scanners use magnetic fields to create detailed images of internal body structures, including the brain, heart, and muscles.
Ultrasound systems
Systems use sound waves to create images for diagnosis and monitoring, including during pregnancy, heart examinations, and procedures.
X-ray systems
Fixed, portable, and moving-image X-ray equipment helps clinicians examine bones, lungs, and other parts of the body.
Patient monitors and electrocardiogram devices
Devices measure and display signs such as heart rhythm, blood pressure, and oxygen levels so care teams can track patients.
Contrast agents and radiopharmaceuticals
These medicines are given before or during scans to make certain tissues or biological activity easier to see in images.
GE HealthCare makes scanners that create images of the body using X-rays, magnetic fields, or sound waves, along with equipment used to guide procedures and monitor patients. It also sells contrast agents and radioactive imaging drugs that help clinicians interpret scans, and provides equipment maintenance, software, and cloud services. Its software includes tools that use artificial intelligence (AI) to help with image analysis and clinical workflows.
Built from GE HealthCare Technologies Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes GE HealthCare Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
$81.85-0.9%Nov 12 close
Figures through September 30, 2026, from the 10-Q filed October 28, 2026
GE HealthCare sells medical imaging scanners and ultrasound systems to hospitals and health systems, plus diagnostic imaging drugs.
Grade A
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 11 quarters of GE HealthCare Technologies Inc.’s grade history. The other 9 go back to February 2024.